Delivery Order SPE2DB22D2007-SPE2DB26FH6PA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $35,815.42 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on October 28, 2025, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This contract is a non-set-aside, competitively awarded delivery order with a firm fixed price ceiling value of $12,911.85 and an ultimate completion date of November 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,237.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 10, 2025, with completion scheduled for September 11, 2025. This non-competitive delivery order was issued under a firm fixed-price arrangement and performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units, with a ceiling value of $19,881.70 and a firm fixed price. This is an unset-aside, competitively awarded contract that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 19, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $16,498.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on November 12, 2025, with completion expected by November 13, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement to support military healthcare operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $7,343.15 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $37,194.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets in quantities of 60 units. This firm fixed-price delivery order, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $15,748.58 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) under a firm fixed-price contract valued at $17,858.49, with an ultimate completion date of June 20, 2025. This non-set-aside delivery order was competitively awarded and represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contractor will perform work at its corporate office...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6PADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $62,741.71 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on October 28, 2025, with completion scheduled for October 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime contractor for this delivery order. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and the U.S. Coast Guard. The current delivery order for Eliquis, an anticoagulant medication commonly used in military and veteran healthcare systems, represents a routine execution of the vendor's standing pharmaceutical supply agreement with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.7k | 10/28/25 |